Karen Lewis, Chief People Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 3,502 shares at $30.43 ($107K) on 2025-01-22, disclosed to the SEC on 2025-01-23.
Seasonal sale ($107k) by Chief People Officer — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.43 | 1,751 | $53K | 50.0% |
| 2 | $30.43 | 1,751 | $53K | 50.0% |
| Total | $30.43 avg | 3,502 | $107K | 100% |
| Filing → |
| APLS | SELL | 2025-01-14 | $46K | — | Filing → |
| APLS | SELL | 2024-01-31 | $139K | — | Filing → |
| APLS | SELL | 2024-01-24 | $546K | — | Filing → |